M
M Lindsay Grayson
Researcher at University of Melbourne
Publications - 118
Citations - 9738
M Lindsay Grayson is an academic researcher from University of Melbourne. The author has contributed to research in topics: Enterococcus faecium & Staphylococcal infections. The author has an hindex of 38, co-authored 113 publications receiving 7432 citations. Previous affiliations of M Lindsay Grayson include Monash Medical Centre & Monash University.
Papers
More filters
Journal ArticleDOI
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Evelina Tacconelli,Elena Carrara,Alessia Savoldi,Stéphan Juergen Harbarth,Marc Mendelson,Dominique L Monnet,Céline Pulcini,Gunnar Kahlmeter,Jan Kluytmans,Yehuda Carmeli,Marc Ouellette,Kevin Outterson,Jean B. Patel,Marco Cavaleri,Edward Cox,Christopher R. Houchens,M Lindsay Grayson,Paul Hansen,Nalini Singh,Ursula Theuretzbacher,Nicola Magrini,Aaron O. Aboderin,Seif Al-Abri,Nordiah Awang Jalil,Nur Benzonana,Sanjay Bhattacharya,Adrian Brink,Francesco Robert Burkert,Otto Cars,Giuseppe Cornaglia,Oliver J. Dyar,Alexander W. Friedrich,Ana Cristina Gales,Sumanth Gandra,Christian G. Giske,Debra A. Goff,Herman Goossens,Thomas Gottlieb,Manuel Guzman Blanco,Waleria Hryniewicz,Deepthi Kattula,Timothy Jinks,Souha S. Kanj,Lawrence Kerr,Marie-Paule Kieny,Yang Soo Kim,Roman S. Kozlov,Jaime Labarca,Ramanan Laxminarayan,Karin Leder,Leonard Leibovici,Gabriel Levy-Hara,Jasper Littman,Surbhi Malhotra-Kumar,Vikas Manchanda,Lorenzo Moja,Babacar Ndoye,Angelo Pan,David L. Paterson,Mical Paul,Haibo Qiu,Pilar Ramon-Pardo,Jesús Rodríguez-Baño,Maurizio Sanguinetti,Sharmila Sengupta,Mike Sharland,Massinissa Si-Mehand,Lynn L. Silver,Wonkeung Song,Martin Steinbakk,Jens Thomsen,Guy E. Thwaites,Jos W. M. van der Meer,Nguyen Van Kinh,Silvio Vega,Maria Virginia Villegas,Agnes Wechsler-Fördös,Heiman F. L. Wertheim,Evelyn Wesangula,Neil Woodford,Fidan O Yilmaz,Anna Zorzet +81 more
TL;DR: Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria, and include antibiotic-resistant bacteria responsible for community-acquired infections.
Journal ArticleDOI
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Benjamin P Howden,John K. Davies,Paul D R Johnson,Paul D R Johnson,Timothy P. Stinear,Timothy P. Stinear,M Lindsay Grayson,M Lindsay Grayson +7 more
TL;DR: It is now becoming clear that sequential point mutations in key global regulatory genes contribute to the hVISA and VISA phenotypes, which are associated predominately with cell wall thickening and restricted vancomycin access to its site of activity in the division septum.
Journal ArticleDOI
Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility
Benjamin P Howden,Peter B. Ward,Patrick G. P. Charles,Tony M. Korman,Andrew Fuller,Philipp du Cros,Elizabeth A Grabsch,Sally A. Roberts,Jenny Robson,Kerry Read,Narin Bak,James C. Hurley,Paul D R Johnson,Arthur J. Morris,Barrie C. Mayall,M Lindsay Grayson,M Lindsay Grayson +16 more
TL;DR: Antibiotic therapy, especially linezolid with or without rifampicin and fusidic acid, in conjunction with surgical debulking is effective therapy for the majority of patients with serious infections (including endocarditis) caused by SA-RVS.
Journal ArticleDOI
Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
TL;DR: Clinical markers of hVISA bacteremia may help focus diagnostic efforts and treatment of methicillin-resistant Staphylococcus aureus and vancomycin-susceptible MRSA.
Journal ArticleDOI
Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations
Julie Storr,Anthony Twyman,Walter Zingg,Nizam Damani,Claire Kilpatrick,Jacqui Reilly,Lesley Price,Matthias Egger,M Lindsay Grayson,Edward Kelley,Benedetta Allegranzi +10 more
TL;DR: Eleven recommendations and three good practice statements form the substance of a new WHO IPC guideline, which is critical for the successful containment of antimicrobial resistance and the prevention of health care-associated infections.